法国PrevHPV整群随机试验中学校接种HPV疫苗干预的过程评估
本研究嵌入法国PrevHPV整群随机对照试验,采用混合方法评估学校接种HPV疫苗干预的实施、影响机制及情境因素。31所学校(14772名青少年)随机实施干预,12所(39%)退出;参与学校中17%青少年交回有效知情同意书,其中89%启动接种。移动接种团队发挥核心作用,满意度高,但知情同意书管理和健康记录缺失为主要障碍。
要点
- 学校接种HPV疫苗干预中,39%的随机学校退出,参与学校仅17%青少年交回有效知情同意书。
- 交回有效知情同意书的青少年中89%启动接种,移动接种团队是实施核心。
- 主要障碍为知情同意书管理和健康记录缺失,建议优化流程并调整立法框架。
核心结论
- 学校接种HPV疫苗干预实施中退出的学校比例较高,但参与学校内知情同意后接种启动率较高。
- 干预满意度高,产生正负群体效应,实施受多因素影响,需针对障碍提出改进建议。
研究设计与样本
- 混合方法研究,嵌入法国PrevHPV整群随机对照试验,时间2021年4月至2022年4月。
- 31所学校(14772名青少年)随机实施学校接种干预,采用活动报告、自填问卷和6个焦点小组收集数据。
主要发现
- 31所随机学校中12所(39%)退出。
- 参与学校中17%青少年交回有效知情同意书,其中89%启动接种。
- 青少年和学校工作人员对接种日满意度高,干预产生正负群体效应。
- 促进因素包括准备接种名单、学校工作人员可用性和积极性;障碍包括知情同意书管理和健康记录缺失。
临床怎么用
- 实施学校接种时应提前准备接种名单,确保学校工作人员可用且积极。
- 需优化知情同意书管理流程,解决健康记录缺失问题。
- 可参考本研究建议为法国2023年全国推广的学校HPV疫苗接种运动提供支持。
局限性
- 原文未明确报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Human papillomavirus vaccine coverage (HPV VC) remains suboptimal in many countries. French authorities launched the PrevHPV research program, which included a cluster randomized controlled trial (cRCT) to evaluate the effectiveness of an 'at-school vaccination' intervention. Within this trial, we conducted a process evaluation of this intervention, specifically analyzing (i) its implementation, (ii) its mechanisms of impact, and (iii) the contextual factors influencing implementation (facilitators/barriers). METHOD: We conducted a mixed-method study embedded in the PrevHPV cRCT (April 2021-April 2022). 'At-school vaccination' consisted of vaccination day(s) on school premises where mobile vaccination teams (MVTs) initiated HPV vaccination free of charge for eligible adolescents (i.e., non-vaccinated adolescents aged 11+). Quantitative data were collected through activity reports and self-administered questionnaires of adolescents and school staff. Qualitative data collected through six focus groups with school staff and MVTs were analyzed using thematic analysis. RESULTS: Of the 31 schools (14,772 adolescents) randomized to implement 'at-school vaccination', 12 (39 %) dropped out. Among the participating schools, analysis of implementation showed that 17 % of adolescents returned valid consent forms, of whom 89 % initiated vaccination. MVTs played a central role in implementing vaccination day(s), supported by several school staff (e.g., school nurses, education assistants). Regarding mechanisms of impacts, satisfaction with the vaccination days was high among adolescents and school staff. The intervention generated both positive and negative group effects among adolescents. Contextual factors that facilitated implementation included the preparation of a list of adolescents to be vaccinated and the availability and motivation of school staff. The main barriers related to the management of consent forms and missing health records. CONCLUSION: We formulated recommendations for implementing at-school vaccination, which may be particularly helpful for the French school HPV vaccination campaigns that were scaled up nationally in 2023. We also discussed potential macro-level improvement strategies, involving modifications to the legislative framework. TRIAL REGISTRATION: Clinicaltrials.gov, NCT04945655. Registered 30 June 2021, https://clinicaltrials.gov/study/NCT04945655.
引用
- Bocquier A, Cadoret S, Fall E, et al. Process evaluation of a school-based vaccination intervention to improve HPV vaccine coverage: A mixed-method study embedded in the French PrevHPV cluster randomized controlled trial. Vaccine. 2025. PMID: 41412015. doi:10.1016/j.vaccine.2025.128122
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。